Glucotropaeolin Extract.

Glucotropaeolin is the marker glucosinolate of maca and is quantified as the standardisation handle for maca preparations. The whole root supplies the plant matrix and myrosinase that convert it to benzyl isothiocyanate.

Ascorbate is the cofactor of myrosinase, the enzyme that cleaves glucotropaeolin to benzyl isothiocyanate. Its presence increases conversion of the intact glucosinolate to the active form.

Sprout material retains active myrosinase, which hydrolyses added glucosinolates that would otherwise depend on gut bacterial conversion. That raises and stabilises isothiocyanate yield from glucotropaeolin.

Benzyl isothiocyanate and sulforaphane are electrophilic isothiocyanates acting on the same Keap1-Nrf2 sensor. Combining them broadens the isothiocyanate profile without changing the mechanism.

Benzyl isothiocyanate is conjugated to glutathione by glutathione S-transferases as its main handling route. Glutathione availability governs its accumulation and export.

Isothiocyanates are excreted as N-acetylcysteine conjugates, and urinary dithiocarbamates are the standard marker of that route. Supplying cysteine supports the normal conjugation step.

Hydrolysis of glucosinolates releases thiocyanate, a competitive inhibitor of iodide uptake at the sodium-iodide symporter. High intake alongside low iodine intake reduces thyroidal iodide accumulation.

Isothiocyanates are electrophiles handled largely through glutathione conjugation and through the antioxidant response element programme, and selenium is required for the glutathione peroxidase family that works alongside that system. Selenium also has a second, separate relevance here: glucosinolate breakdown yields thiocyanate ion, which competes with iodide at the sodium-iodide symporter, and selenium-dependent deiodinases sit downstream in normal thyroid hormone handling. Adequacy is the frame, not loading.

Cysteine is the rate-limiting amino acid for glutathione synthesis, and glutathione is what conjugates benzyl isothiocyanate in the first step of the mercapturic acid pathway. Cysteine availability therefore sets the capacity of the route that handles the active breakdown product. This is textbook conjugation biochemistry rather than a tested combination.

Methionine feeds the transsulfuration pathway that supplies cysteine, and so indirectly the glutathione pool used to conjugate isothiocyanates. The step depends on vitamin B6 and B12 status, which is why single-nutrient reasoning misleads here. Adequate protein intake usually covers this without a supplement.

Glutathione is a tripeptide of glutamate, cysteine and glycine, so glycine is one of its three building blocks. It is rarely limiting compared with cysteine, but a low-protein intake can make it so. The relationship is to the conjugation pathway, not to the isothiocyanate itself.

Pyridoxal 5-phosphate is the cofactor for cystathionine beta-synthase and cystathionine gamma-lyase, the two transsulfuration enzymes that convert homocysteine to cysteine. Without adequate B6 the cysteine supply for glutathione conjugation is constrained. This is a cofactor dependency of the clearance route.

Isothiocyanate metabolites are also handled by phase II glucuronidation, and calcium D-glucarate is used on the reasoning that it inhibits beta-glucuronidase and so reduces deconjugation in the gut. The direction of that effect is mechanistically coherent; the human data behind it is limited. Combining them is a pathway argument, not a measured pairing.

DIM arises from indole-3-carbinol, the breakdown product of a different glucosinolate, and like isothiocyanates it modulates phase I and phase II enzyme expression. Two glucosinolate-derived compounds acting on overlapping regulatory pathways is the reason they co-occur in formulas. They are distinct molecules with distinct targets, so this is complementary rather than interchangeable.

Quercetin and isothiocyanates both influence Nrf2-driven antioxidant response element signalling, by different upstream routes. Co-formulation is common in plant-extract blends for that reason. What is documented is gene and enzyme expression in laboratory systems, which are markers rather than human outcomes.

EGCG is itself an electrophile-reactive polyphenol that engages thiol chemistry and Nrf2 signalling. Because benzyl isothiocyanate is highly thiol-reactive, direct chemical interaction between the two in solution is plausible and would reduce the free isothiocyanate available. This is a formulation caution based on reactivity, not a documented loss.

Alpha-lipoic acid carries a reactive dithiolane ring, and thiols react readily with isothiocyanates to form dithiocarbamates. That means a thiol-rich co-ingredient can consume the active before it is absorbed if the two sit together in solution. Separating them in the formulation, or using a dry blend, is the practical response.

Silymarin is studied for its effects on hepatic phase II enzyme expression and on glutathione content in liver tissue, the same system that clears isothiocyanates. The two are combined on that shared-pathway reasoning. Reported endpoints for each are enzyme and marker measurements rather than clinical outcomes.

When plant myrosinase has been destroyed by heat, conversion of glucosinolate to isothiocyanate depends almost entirely on bacterial thioglucosidase activity in the colon. Several Lactobacillus and Bacteroides strains carry that activity, and it varies widely between individuals. This is the most consequential and least appreciated determinant of whether a heat-processed glucosinolate extract does anything at all.

Lactobacillus plantarum strains have been reported to hydrolyse glucosinolates in vitro, releasing the isothiocyanate from the intact glycoside. Supplying such a strain alongside a myrosinase-inactivated extract is the synbiotic logic behind the pairing. Whether it works in a given person depends on the strain and on the resident community it joins.

Bifidobacteria contribute to the colonic glycosidase pool that acts on intact plant glycosides. Direct evidence for benzyl glucosinolate hydrolysis by this genus is thinner than for other groups. Include this as a plausible contributor, not an established converter.

Tyrosine is the amino acid backbone that is iodinated during normal thyroid hormone synthesis, and the thiocyanate ion released from glucosinolate breakdown competes with iodide for uptake on the sodium-iodide symporter. Adequate iodine and tyrosine intake is therefore the relevant context for anyone taking a glucosinolate-rich extract at high dose over time. This describes support of a normal process, not action on any condition.

Nasturtium preparations and cranberry are combined in traditional and commercial urinary-support formulas, which is a formulation and historical-use pairing rather than a demonstrated pharmacological interaction. No combination trial grounds it and no shared mechanism is established. It belongs on the page as use context, clearly labelled as such.

D-mannose appears alongside nasturtium-derived ingredients in urinary-support products, so the two are frequently co-dosed. The basis is product design, not a documented interaction between the molecules. Presented as anything more than that it would overstate what is known.